GSK plc
Tracked across 20 events · 406 articles · First seen Feb 10, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: GSK plc is facing a class action lawsuit for allegedly making false and misleading statements regarding the safety of its drug Zantac and its awareness of NDMA contamination. This event could lead to significant financial liabilities for GSK plc.
Feb 10, 2025 · 34 articles
Tech
Researchers have reported a significant medical breakthrough with bepirovirsen, an experimental drug for hepatitis B, which has achieved a 'functional cure' in approximately 20% of patients in two international studies. This means patients were able…
Impact: As a developer and funder of bepirovirsen, GSK plc stands to benefit significantly from the drug's potential approval and market success, enhancing its reputation and financial outlook in the pharmaceutical industry.
May 28, 2026 · 8 articles
Business
GSK plc>>> has agreed to acquire GSK plc>>>, a US cancer drug firm, for $10.6 billion (£8 billion) in an all-cash deal. This acquisition, GSK plc>>>'s largest in over a decade, aims to significantly expand…
Impact: GSK plc>>> is being acquired by GSK plc>>> for $10.6 billion, representing a 40% premium to its last closing price. This acquisition validates GSK plc>>>'s innovative work in developing targeted cancer therapies, particularly for lung cancer, and provides its shareholders with significant value.
Jun 09, 2026 · 56 articles
Regulatory
Impact: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
Business
Impact: GSK plc has adopted a more aggressive M&A approach following recent CEO transitions, contributing to the overall increase in dealmaking.
May 01, 2026 · 6 articles
Regulatory
Roche announced the European Union In Vitro Diagnostic Regulation (IVDR) approval of several label expansions for its VENTANA MMR RxDx Panel. This immunohistochemistry (IHC) companion diagnostic test identifies cancer patients' mismatch repair (MMR) status, which…
Impact: GSK plc benefits from the expanded label of the VENTANA MMR RxDx Panel as it identifies patients eligible for its Dostarlimab therapy, potentially increasing the drug's market reach.
Jun 11, 2026 · 6 articles
Tech
New research presented at the 2026 American Society of Clinical Oncology>>> Annual Meeting indicates that GLP-1 medications, widely used for weight loss and diabetes, may significantly reduce the risk of developing various cancers, including breast…
Impact: GSK plc>>>'s drug Avodart is mentioned in a comparison study where GLP-1s were associated with lower rates of prostate cancer diagnoses.
Jun 02, 2026 · 37 articles
Domestic
Impact: GSK plc, a hepatitis B vaccine maker, defended its products as safe, and its shares finished 0.3% lower.
Dec 05, 2025 · 7 articles
Business
Global stock markets experienced a significant rally, primarily fueled by a stronger-than-expected quarterly report from Nvidia, which saw its profit and revenue surge due to high demand for its AI chips. This boosted technology shares…
Impact: GSK plc>>> agreed to acquire GSK plc>>> for $10.6 billion, marking its largest deal in years and expanding its presence in cancer drug development.
May 20, 2026 · 66 articles
International
The market is experiencing significant volatility, primarily driven by the fluctuating performance of artificial intelligence (AI) stocks. Major indexes like the S&P 500>>>, Nasdaq Composite>>>, and Dow Jones Industrial Average>>> have seen sharp drops and…
Impact: GSK plc>>> soared after GSK plc>>> agreed to acquire the biotech company for $10.6 billion.
Jun 04, 2026 · 92 articles
Domestic
Impact: GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.
Sep 22, 2025 · 6 articles
Business
Innoviva, a diversified biopharmaceutical company, announced its participation in two upcoming investor conferences in June 2026. Management will engage in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8,…
Impact: GSK plc is a partner of Innoviva, from whom Innoviva receives royalties on sales of respiratory assets.
Jun 01, 2026 · 6 articles
Business
Haleon, a British consumer health company, announced a strategic investment of approximately ₹2,000 crore (£175 million) to establish its first manufacturing facility in India. The greenfield plant will be located in Pithampur, India — Madhya…
Impact: GSK plc is mentioned as the former parent company from which Haleon was spun off in 2022, providing historical context to Haleon's current operations.
Jun 08, 2026 · 13 articles
Business
Impact: Andrew Witty previously served as CEO of GSK plc before joining UnitedHealth Group.
May 13, 2025 · 7 articles
100
GSK plc developed drugBepirovirsen achieves...
100
GSK plc in talks to buy GSK plcGSK acquires Nuvalent for $10.6B
85
GSK plc developed treatments forGSK acquires Nuvalent for $10.6B
70
United States — Food and Drug Administration reviewing drugs GSK plcGSK acquires Nuvalent for $10.6B
69
GSK plc will launch tender offer GSK plcNvidia Earnings, Samsung...
69
GSK plc will launch tender offer GSK plcAI Stocks Volatility, Iran...
35
GSK plc agreed to buyNvidia Earnings, Samsung...
35
GSK plc agreed to buyAI Stocks Volatility, Iran...
20
Haleon spun off GSK plcHaleon invests in India...
+ 8 more relationships
View on Dashboard
NEWSDESK
Track GSK plc live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard